Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616759 · ClinicalTrials.gov registry record · NA
The Effect on Cognition of Terminating ECT Induced Seizures With Propofol
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00616759: Completed NA study, sponsored by Loma Linda University.
NCT00616759 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00616759, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Participating subjects are those who are referred for electroconvulsive therapy (ECT) for severe depression who have agreed to the protocol. The control group receives ECT as usual. The other group receives propofol to terminate the ECT-induced seizure timed so that the seizure lasts at least 25 seconds. Extensive neuropsychological testing is being done on both groups before beginning ECT and within 48 hours after the 6th treatment. Multiple markers of the rapidity of recovery from anesthesia are being obtained from all subjects for 6 ECTs.
Primary Outcome
WMS-III Auditory Delayed Index is a measure of memory functioning. The results given are the post-ECT testing results. A smaller number indicates less memory disturbance on this scale. The range of scores is between 0-140 with higher scores indicating better memory function.
Interventions
- DRUG propofol
- PROCEDURE electroconvulsive therapy
- PROCEDURE electroconvulsive therapy plus propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-09 |
| Est. Completion | 2010-03-24 |
| Phase | NA |
What the finished NCT00616759 record still lists
NCT00616759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which propofol is the first listed.
NCT00616759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00616759 about?
NCT00616759 is a clinical study titled "The Effect on Cognition of Terminating ECT Induced Seizures With Propofol". Participating subjects are those who are referred for electroconvulsive therapy (ECT) for severe depression who have agreed to the protocol. The control group receives ECT as usual. The other group receives propofol to terminate the ECT-induced seizure timed so that the seizure lasts at least 25 sec...
What is the current status of trial NCT00616759?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2006-09. Estimated completion is 2010-03-24.
What interventions are being tested in trial NCT00616759?
The interventions under investigation include: propofol (DRUG), electroconvulsive therapy (PROCEDURE), electroconvulsive therapy plus propofol (PROCEDURE).
Who is sponsoring clinical trial NCT00616759?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00616759's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia